公開日期 | 標題 | 作者 | 來源出版物 | scopus | WOS | 全文 |
2022 | New bipolar host materials for high power efficiency green thermally activated delayed fluorescence OLEDs | Chen C.-H.; Lin S.-C.; Lin B.-Y.; Li C.-Y.; Kong Y.-C.; Chen Y.-S.; Fang S.-C.; Chiu C.-H.; JIUN-HAW LEE ; KEN-TSUNG WONG ; Lin C.-F.; Hung W.-Y.; Chiu T.-L. | Chemical Engineering Journal | 9 | 7 | |
2009 | A new system for forensic physicians in Taiwan | Chiu C.-H.; Kuo T.-L.; YAO-CHANG CHEN ; Yang C.-P. | Legal Medicine | 1 | 0 | |
2020 | Nivolumab safety and efficacy in advanced, platinum-resistant, non-small cell lung cancer, radical radiotherapy-ineligible patients: A phase II study in Taiwan | Chen Y.-M.; CHIH-HSIN YANG ; Su W.-C.; Chong I.-W.; Hsia T.-C.; Lin M.-C.; Chang G.-C.; Chiu C.-H.; CHAO-CHI HO ; Wu S.-Y.; Hung J.-Y.; Wang C.-C.; Yang T.-Y.; CHONG-JEN YU | Journal of the Formosan Medical Association | 8 | 5 | |
2008 | Non-toxic phototriggered gene transfection by PAMAM-porphyrin conjugates | MING-JIUM SHIEH ; Peng C.-L.; PEI-JEN LOU ; Chiu C.-H.; Tsai T.-Y.; Hsu C.-Y.; Yeh C.-Y.; Lai P.-S. | Journal of Controlled Release | 100 | 87 | |
2007 | Nontyphoidal Salmonella bacteremia in previously healthy children: Analysis of 199 episodes | Tsai M.-H.; Huang Y.-C.; Chiu C.-H.; Yen M.-H.; LUAN-YIN CHANG ; Lin P.-Y.; Lin T.-Y. | Pediatric Infectious Disease Journal | 37 | 31 | |
2019 | An one-pot two-step automated synthesis of [18F]T807 injection, its biodistribution in mice and monkeys, and a preliminary study in humans | Huang Y.-Y.; MING-JANG CHIU et al. ; RUOH-FANG YEN ; Tsai C.-L.; Hsieh H.-Y.; Chiu C.-H.; Wu C.-H.; LING-WEI HSIN ; KAI-YUAN TZEN ; Cheng C.-Y.; Ma K.-H.; Shiue C.-Y. | PLoS ONE | 2 | 3 | |
2020 | An Open-Label, Single-Arm, Two-Stage, Multicenter, Phase II Study to Evaluate the Efficacy of TLC388 and Genomic Analysis for Poorly Differentiated Neuroendocrine Carcinomas | Chen M.-H.; Chou W.-C.; Hsiao C.-F.; Jiang S.S.; Tsai H.-J.; Liu Y.-C.; CHIUN HSU ; Shan Y.-S.; Hung Y.-P.; Hsich C.-H.; Chiu C.-H.; Liu T.-C.; Cho S.-F.; Liu T.-W.; Chao Y. | Oncologist | 7 | 6 | |
2018 | Optimal Advertising Budget Allocation in Luxury Fashion Markets with Social Influences: A Mean-Variance Analysis | Chiu C.-H.; TSAN MING CHOI ; Dai X.; Shen B.; Zheng J.-H. | Production and Operations Management | | | |
2010 | Optimal pricing and stocking decisions for newsvendor problem with value-at-risk consideration | Chiu C.-H.; TSAN MING CHOI | IEEE Transactions on Systems, Man, and Cybernetics Part A:Systems and Humans | | | |
2011 | Periodic review multiperiod inventory control under a mean-variance optimization objective | TSAN MING CHOI ; Chiu C.-H.; Fu P.-L. | IEEE Transactions on Systems, Man, and Cybernetics Part A:Systems and Humans | | | |
2016 | PET imaging of serotonin transporters with 4-[ 18 F]-ADAM in a parkinsonian rat model with porcine neural xenografts | Chiu C.-H.; Li I.-H.; Weng S.-J.; Huang Y.-S.; Wu S.-C.; Chou T.-K.; Huang W.-S.; Liao M.-H.; Shiue C.-Y.; Cheng C.-Y.; SHINN-CHIH WU ; Liao, M.-H. | Cell Transplantation | 7 | 6 | |
2015 | A potent virus-specific antibody-secreting cell response to acute enterovirus 71 infection in children | Kuan-Ying A. Huang ; Lin J.-J.; Chiu C.-H.; Yang S.; Tsao K.-C.; Huang Y.-C.; Lin T.-Y. | Journal of Infectious Diseases | 13 | 13 | |
2006 | Predictive factors of gefitinib antitumor activity in East Asian advanced non-small cell lung cancer patients | Chang G.-C.; Tsai C.-M.; Chen K.-C.; CHONG-JEN YU ; JIN-YUAN SHIH ; Yang T.-Y.; Lin C.-P.; Hsu J.-Y.; Chiu C.-H.; Perng R.-P.; PAN-CHYR YANG ; CHIH-HSIN YANG | Journal of Thoracic Oncology | 44 | 35 | |
2009 | Price wall or war: The pricing strategies for retailers | Chiu C.-H.; TSAN MING CHOI ; Li D. | IEEE Transactions on Systems, Man, and Cybernetics Part A:Systems and Humans | | | |
2011 | Price, rebate, and returns supply contracts for coordinating supply chains with price-dependent demands | Chiu C.-H.; TSAN MING CHOI ; Tang C.S. | Production and Operations Management | | | |
2004 | Prognostic implications of myoclonic jerk in children with enterovirus infection | Lu H.-K.; Lin T.-Y.; Hsia S.-H.; Chiu C.-H.; Huang Y.-C.; Tsao K.-C.; LUAN-YIN CHANG | Journal of Microbiology, Immunology and Infection | 25 | 0 | |
2019 | Prospective multinational serosurveillance study of Bordetella pertussis infection among 10- to 18-year-old Asian children and adolescents | Son S.; Thamlikitkul V.; Chokephaibulkit K.; Perera J.; Jayatilleke K.; PO-REN HSUEH ; CHUN-YI LU ; Balaji V.; Moriuchi H.; Nakashima Y.; Lu M.; Yang Y.; Yao K.; Kim S.H.; Song J.H.; Kim S.; Kim M.-J.; Heininger U.; Chiu C.-H.; Kim Y.-J. | Clinical Microbiology and Infection | 14 | 12 | |
2020 | Ramucirumab or placebo plus erlotinib in EGFR-mutated, metastatic non-small-cell lung cancer: East Asian subset of RELAY | Nishio M.; Seto T.; Reck M.; Garon E.B.; Chiu C.-H.; Yoh K.; Imamura F.; Park K.; JIN-YUAN SHIH ; Visseren-Grul C.; Frimodt-Moller B.; Zimmermann A.; Homma G.; Enatsu S.; Nakagawa K.; RELAY Study Investigators | Cancer science | 17 | 12 | |
2019 | Ramucirumab plus erlotinib in patients with untreated, EGFR-mutated, advanced non-small-cell lung cancer (RELAY): a randomised, double-blind, placebo-controlled, phase 3 trial | Nakagawa K.; Garon E.B.; Seto T.; Nishio M.; Ponce Aix S.; Paz-Ares L.; Chiu C.-H.; Park K.; Novello S.; Nadal E.; Imamura F.; Yoh K.; JIN-YUAN SHIH ; Au K.H.; Moro-Sibilot D.; Enatsu S.; Zimmermann A.; Frimodt-Moller B.; Visseren-Grul C.; Reck M.; Chu Q.; Cortot A.; Pujol J.-L.; Fabre E.; Lamour C.; Bischoff H.; Kollmeier J.; Kimmich M.; Engel-Riedel W.; Hammerschmidt S.; Schütte W.; Syrigos K.; Ho J.C.M.; Au K.-H.; Ardizzoni A.; Pasello G.; Gregorc V.; Del Conte A.; Galetta D.; Takahashi T.; Kumagai T.; Hotta K.; Goto Y.; Hosomi Y.; Sakai H.; Takiguchi Y.; Kim Y.H.; Kurata T.; Yamaguchi H.; Daga H.; Okamoto I.; Satouchi M.; Ikeda S.; Kasahara K.; Atagi S.; Azuma K.; Aoe K.; Horio Y.; Yamamoto N.; Tanaka H.; Watanabe S.; Nogami N.; Ozaki T.; Koyama R.; Hirashima T.; Kaneda H.; Tomii K.; Fujita Y.; Seike M.; Nishimura N.; Kato T.; Ichiki M.; Saka H.; Hirano K.; Nakahara Y.; Sugawara S.; Kim S.-W.; Min Y.J.; Lee H.W.; Kang J.-H.; An H.J.; Lee K.H.; Kim J.-S.; Lee G.-W.; Lee S.Y.; Alexandru A.; Udrea A.A.; Juan-Vidal Ó.; Nadal-Alforja E.; Gil-Bazo I.; Ponce-Aix S.; Rubio-Viqueira B.; Alonso Garcia M.; Felip Font E.; Fuentes Pradera J.; Coves Sarto J.; Lin M.-C.; Su W.-C.; Hsia T.-C.; Chang G.-C.; Wei Y.-F.; Su J.; Cicin I.; Goksel T.; Harputluoglu H.; Ozyilkan O.; Henning I.; Popat S.; Hatcher O.; Mileham K.; Acoba J.; Garon E.; Jung G.; Raj M.; Martin W.; Dakhil S. | The Lancet Oncology | 397 | 341 | |
2022 | A randomized controlled trial of heterologous ChAdOx1 nCoV-19 and recombinant subunit vaccine MVC-COV1901 against COVID-19 | Chen C.-J.; Yang L.-Y.; Chang W.-Y.; Huang Y.-C.; Chiu C.-H.; Shih S.-R.; Huang C.-G.; Kuan-Ying A. Huang | Nature Communications | 12 | 5 | |